{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:03:09Z","timestamp":1783825389389,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","oarsijournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.joca.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T17:58:46Z","timestamp":1720979926000},"page":"1601-1609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of preexisting articular bone pathology in patients with osteoarthritis screened for fasinumab clinical trials identified by X-ray or magnetic resonance imaging"],"prefix":"10.1016","volume":"32","author":[{"given":"Stephen J.","family":"DiMartino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-1711","authenticated-orcid":false,"given":"Tuhina","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhil","family":"Zaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garen","family":"Manvelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2463-3034","authenticated-orcid":false,"given":"Ned","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Geba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-0414","authenticated-orcid":false,"given":"Paula","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2024.07.001_bib1","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2147\/JPR.S310368","article-title":"Moderate to severe osteoarthritis pain and its impact on patients in the United States: a national survey","volume":"14","author":"Schepman","year":"2021","journal-title":"J Pain Res"},{"key":"10.1016\/j.joca.2024.07.001_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2024.07.001_bib3","series-title":"Osteoarthritis (OA)","volume":"vol. 2021","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"10.1016\/j.joca.2024.07.001_bib4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/acr.20614","article-title":"Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis","volume":"63","author":"Bartlett","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2024.07.001_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1759720X16658032","article-title":"Best performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative","volume":"8","author":"Driban","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.joca.2024.07.001_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006395","article-title":"Clinico-radiological diagnosis and grading of rapidly progressive osteoarthritis of the hip","volume":"96","author":"Zazgyva","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.joca.2024.07.001_bib7","first-page":"1425","article-title":"[Unexpected rapidly destructive hip diseases]","volume":"78","author":"Lequesne","year":"1970","journal-title":"Presse Med"},{"key":"10.1016\/j.joca.2024.07.001_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2024.07.001_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/acr.23884","article-title":"Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: a systematic review and meta-analysis","volume":"72","author":"Osani","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2024.07.001_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jgs.12148","article-title":"Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults","volume":"61","author":"Rolita","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.joca.2024.07.001_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001029","article-title":"The opioid epidemic: helping rheumatologists prevent a crisis","volume":"5","author":"Trouvin","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.joca.2024.07.001_bib12","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.41012","article-title":"The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: a phase IIb\/III double-blind, placebo-controlled, randomized clinical trial","volume":"71","author":"Dakin","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2024.07.001_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/annrheumdis-2020-217259","article-title":"Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II\/III randomised clinical trial","volume":"80","author":"Dakin","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.joca.2024.07.001_bib14","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.joca.2014.10.005","article-title":"Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies","volume":"23","author":"Hochberg","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl 107","key":"10.1016\/j.joca.2024.07.001_bib15","first-page":"85","article-title":"Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain","volume":"35","author":"Miller","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.joca.2024.07.001_bib16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.joca.2014.09.015","article-title":"Imaging atlas for eligibility and on-study safety of potential knee adverse events in anti-NGF studies (Part 1)","volume":"23","author":"Roemer","year":"2015","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.joca.2024.07.001_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","article-title":"Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee","volume":"155","author":"Tiseo","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.joca.2024.07.001_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/ijms18030548","article-title":"Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury","volume":"18","author":"Keefe","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2024.07.001_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2024.07.001_bib20","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2024.07.001_bib21","article-title":"Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II\/III randomised clinical trial","author":"Dakin","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2024.07.001_bib22","unstructured":"US Food and Drug Administration. Summary Minutes of the Arthritis Advisory Committee Meeting March 12, 2012, vol. 20232012."},{"key":"10.1016\/j.joca.2024.07.001_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.joca.2024.07.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2020.100089","article-title":"Prevalence of undiagnosed subchondral insufficiency fractures of the knee in middle age adults with knee pain and suspected meniscal tear","volume":"2","author":"Huizinga","year":"2020","journal-title":"Osteoarthr Cartil Open"},{"key":"10.1016\/j.joca.2024.07.001_bib25","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00256-019-03245-6","article-title":"Subchondral insufficiency fracture of the knee: grading, risk factors, and outcome","volume":"48","author":"Sayyid","year":"2019","journal-title":"Skelet Radiol"},{"key":"10.1016\/j.joca.2024.07.001_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00256-023-04354-z","article-title":"A call for screening MRI as a tool for osteoarthritis clinical trials","author":"Guermazi","year":"2023","journal-title":"Skelet Radiol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458424012743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458424012743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T19:43:34Z","timestamp":1731354214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458424012743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1063458424012743"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2024.07.001","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of preexisting articular bone pathology in patients with osteoarthritis screened for fasinumab clinical trials identified by X-ray or magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}